A drug that costs less than 2 euros a day can help treat severe COVID-19 patients

Metoprolol is a drug widely used to treat cardiovascular diseases and is beneficial to COVID-19 patients

The most severe form of COVID-19 is severe respiratory failure, which requires intubation and is associated with high mortality

The research was led by Dr.

Madrid-covid is a randomized clinical trial conducted by the FJD Hospital CNIC in close cooperation with cardiology, ICU, pulmonary and biobank services

When introducing the study, Dr.

One of the authors, CNIC Ramón y Cajal researcher Eduardo Oliver, confirmed that intravenous metilol treatment "significantly reduced lung neutrophil infiltration and improved oxygenation

Dr.

Therefore, the researchers proposed that intravenous metoprolol is a "promising intervention that can improve the prognosis of patients with severe COVID-19

Co-first author Agustín Clemente-Moragón added: "The effect of metoprolol on the excessive activation of inflammatory cells in acute respiratory distress syndrome (ARDS) is unique to this receptor blocker

Original search:

DOI 10.

Metoprolol in Critically Ill Patients With COVID-19